Simple Hysterectomy Not Inferior for Pelvic Recurrence in Cervical Cancer
Simple hysterectomy not inferior to radical hysterectomy for patients with low-risk cervical cancer
Treatment Modification Aids Chemo Tolerability in Seniors With Advanced Cancer
Primary treatment modifications tied to lower risk for toxic effects and functional decline
Delayed Melanoma Care During Pandemic Proved Costly
Delayed diagnoses due to pandemic lockdowns tied to years of life lost
Annual Breast Cancer Screening From Ages 40 to 79 Years Is Best Strategy
Annual screening appears to provide the greatest benefit and lowest risk
Enobosarm Has Antitumor Activity in ER-Positive, HER2-Negative Advanced Breast Cancer
At 24 weeks, 32 and 29 percent of patients in the 9-mg and 18-mg groups had clinical benefit
Observed Rates of Cancer Diagnoses Lower Than Expected in Pandemic
Rate of all-sites cancer incidence was 28.6 percent lower than expected during the height of the COVID-19 pandemic response
Multitarget Fecal Immunochemical Test Increases Detection of Advanced Adenoma
mtFIT-based screening could reduce incidence of colorectal cancer by 21 percent and associated mortality by 18 percent
Increased Cancer Risk Seen in Families of Men With Subfertility
In a recent study, 13 clusters of familial multicancer patterns identified in families of azoospermic men
Level of Burnout Higher for Women in Health Care Occupations
Gender-specific factors that have direct link to well-being include job satisfaction, psychological health, and work-life integration
Tislelizumab Plus Chemotherapy Beneficial for Resectable NSCLC
Significant benefit seen for neoadjuvant tislelizumab plus chemotherapy with adjuvant tislelizumab
